Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
144
Filing Date
2/14/2024
Updated
2/15/24, 9:02 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities